Global Dermatology Drugs Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2031

Запрос на TOC Запрос на TOC Обратиться к аналитику Обратиться к аналитику Купить сейчас Купить сейчас Узнать перед покупкой Узнать перед покупкой Бесплатный пример отчета Бесплатный пример отчета

Global Dermatology Drugs Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2031

  • Healthcare
  • Upcoming Report
  • Sep 2024
  • Global
  • 350 Pages
  • Количество таблиц: 60
  • Количество рисунков: 220

Global Dermatology Drugs Market

Размер рынка в млрд долларов США

CAGR :  % Diagram

Chart Image USD 20.79 Billion USD 45.37 Billion 2021 2031
Diagram Прогнозируемый период
2022 –2031
Diagram Размер рынка (базовый год)
USD 20.79 Billion
Diagram Размер рынка (прогнозируемый год)
USD 45.37 Billion
Diagram CAGR
%
Diagram Основные игроки рынка
  • LUPIN
  • Novartis AG
  • F. Hoffmann-La Roche Ltd
  • Pfizer
  • Sanofi

>Global Dermatology Drugs Market Segmentation, By Dermatological Diseases (Acne, Dermatitis, Psoriasis, Skin Cancer, Others), Prescription mode  (Prescription Based Drugs, Over Counter Drugs), Drug Classification (Corticosteroids, Astringents, Anti-Inflammatory & Antipruritic Drugs, Anti-Infective/Antibacterial Drugs, Antifungal Drugs), Route Of Administration (Topical, Oral, Parenteral Administration), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), End User (Hospitals, Speciality Clinics, Cosmetic Centres) – Industry Trends and Forecast to 2031.

Dermatology Drugs Market

Dermatology Drugs Market Analysis

The global dermatology drugs market is expected to witness significant growth during the forecast period. The global dermatological drugs market is expected to grow due to driving factors such as the availability of medical resources for detecting and treating skin diseases is  expected to see rise in the market growth. COVID-19 also had an impact on the market growth.

Dermatology Drugs Market Size

Global dermatology drugs Market size was valued at USD 20.79 million in 2023 and is projected to reach USD 45.37 billion by 2031, with a CAGR of 10.25% during the forecast period of 2024 to 2031.

Report Scope and Market Segmentation       

Attributes

Dermatology Drugs Key Market Insights

Segmentation

  • By Dermatological Diseases: Acne, Dermatitis, Psoriasis, Skin Cancer, Others
  • By Prescription mode  : Prescription Based Drugs, Over Counter Drugs
  • By Drug Classification: Corticosteroids, Astringents, Anti-Inflammatory & Antipruritic Drugs, Anti-Infective/Antibacterial Drugs, Antifungal Drugs
  • By Route Of Administration: Topical, Oral, Parenteral Administration
  • By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
  • By End User: Hospitals, Speciality Clinics, Cosmetic Centres

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Key Market Players

LUPIN (India), Novartis AG (Switzerland), F. Hoffmann-La Roche Ltd (Switzerland), Pfizer Inc. (U.S.), Sanofi (France), Amgen inc. (U.S.), Lilly (U.S.), AstraZeneca (U.K.), AbbVie Inc (U.S.), Johnson & Johnson Private Limited (U.S.), LEO Pharma A/S (Denmark), Merck & Co., Inc (U.S.), Bausch Health Companies Inc (Canada) and Bristol-Myers Squibb Company (U.S.)

Market Opportunities

  • Increasing Elderly Population

Dermatology Drugs Market Definition

Dermatology is a therapy area dealing with skin, hair, and nails diseases, where the most common conditions are psoriasis, eczema, and acne vulgaris. Dermatology drugs are used to manage and treat diseases related to skin, nail, hair, and genital membranes. 

Dermatology Drugs Market Dynamics

Drivers

  • Rise in Clinical Studies

The dermatologicals market is expected to rise as more clinical studies are conducted to assess the efficacy and safety of a variety of medicinal medications. For instance, the pharmaceutical company Amgen Inc. announced the favourable findings of a phase 3 placebo-controlled, double-blind clinical research in December 2021. The trial's objective is to evaluate Otezla's effectiveness in managing moderate to severe psoriasis.

Opportunities

  • Increasing Elderly Population

The development of the dermatological pharmaceuticals market is fueled by the loss of human skin's ability to function properly with ageing, leading to numerous skin illnesses. Additionally, as we age, the body begins to experience several additional issues, including slower wound healing, increased sensitivity to ultraviolet (UV) radiation, increased susceptibility to infections, and decreased subcutaneous fat. Due to the increased likelihood of numerous skin conditions, the need for dermatological medications has skyrocketed.

Restraints/Challenges

  • High Cost

The huge expenditure associated with these drugs surely hamper the market growth. Several market players make huge investments in manufacturing new drugs to faster the recovery process; in return, the cost is increased.

This global dermatology drugs market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global dermatology drugs market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Dermatology Drugs Market Scope

The global dermatology drugs market is segmented on the basis of type, technology and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Dermatological Diseases

Prescription mode 

  • Prescription Based Drugs
  • Over Counter Drugs

Drug Classification

  • Corticosteroids
  • Astringents
  • Anti-Inflammatory & Antipruritic Drugs
  • Anti-Infective/Antibacterial Drugs
  • Antifungal Drugs

Route of Administration

  • Topical
  • Oral
  • Parenteral Administration

Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

End-User

  • Hospitals
  • Speciality Clinics
  • Cosmetic Centres

 Dermatology Drugs Market Regional Analysis

The global dermatology drugs market is analysed and market size insights and trends are provided by type, technology and end-user as referenced above.

The major countries covered in the global dermatology drugs market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Europe and Asia-Pacific dominate the dermatology drugs market due to rising skin disease awareness, a growing number of patients suffering from acne, vitiligo, and dermatitis, a growing patient pool of a wide range of dermatological conditions, and patients' willingness to pay for expensive medications in these regions.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Dermatology Drugs Market Share

The global dermatology drugs market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global dermatology drugs market

Dermatology Drugs Market Leaders Operating in the Market Are:

  • LUPIN (India)
  • Novartis AG (Switzerland)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Pfizer Inc. (U.S.)
  • Sanofi (France)
  • Amgen inc. (U.S.)
  • Lilly (U.S.)
  • AstraZeneca (U.K.)
  • AbbVie Inc (U.S.)
  • Johnson & Johnson Private Limited (U.S.)
  • LEO Pharma A/S (Denmark)
  • Merck & Co., Inc (U.S.)
  • Bausch Health Companies Inc (Canada)
  • Bristol-Myers Squibb Company (U.S.)

Latest Developments in Dermatology Drugs Market

Perrigo Company plc, a leading global provider of quality and affordable self-care products, announced in april 2020 that it acquired three Eastern European OTC skincare and hair loss treatment brands (Emolium, Iwostin, and Loxon) from Sanofi.  


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Интерактивная панель анализа данных
  • Панель анализа компании для возможностей с высоким потенциалом роста
  • Доступ аналитика-исследователя для настройки и запросов
  • Анализ конкурентов с помощью интерактивной панели
  • Последние новости, обновления и анализ тенденций
  • Используйте возможности сравнительного анализа для комплексного отслеживания конкурентов
Запросить демонстрацию

Методология исследования

Сбор данных и анализ базового года выполняются с использованием модулей сбора данных с большими размерами выборки. Этап включает получение рыночной информации или связанных данных из различных источников и стратегий. Он включает изучение и планирование всех данных, полученных из прошлого заранее. Он также охватывает изучение несоответствий информации, наблюдаемых в различных источниках информации. Рыночные данные анализируются и оцениваются с использованием статистических и последовательных моделей рынка. Кроме того, анализ доли рынка и анализ ключевых тенденций являются основными факторами успеха в отчете о рынке. Чтобы узнать больше, пожалуйста, запросите звонок аналитика или оставьте свой запрос.

Ключевой методологией исследования, используемой исследовательской группой DBMR, является триангуляция данных, которая включает в себя интеллектуальный анализ данных, анализ влияния переменных данных на рынок и первичную (отраслевую экспертную) проверку. Модели данных включают сетку позиционирования поставщиков, анализ временной линии рынка, обзор рынка и руководство, сетку позиционирования компании, патентный анализ, анализ цен, анализ доли рынка компании, стандарты измерения, глобальный и региональный анализ и анализ доли поставщика. Чтобы узнать больше о методологии исследования, отправьте запрос, чтобы поговорить с нашими отраслевыми экспертами.

Доступна настройка

Data Bridge Market Research является лидером в области передовых формативных исследований. Мы гордимся тем, что предоставляем нашим существующим и новым клиентам данные и анализ, которые соответствуют и подходят их целям. Отчет можно настроить, включив в него анализ ценовых тенденций целевых брендов, понимание рынка для дополнительных стран (запросите список стран), данные о результатах клинических испытаний, обзор литературы, обновленный анализ рынка и продуктовой базы. Анализ рынка целевых конкурентов можно проанализировать от анализа на основе технологий до стратегий портфеля рынка. Мы можем добавить столько конкурентов, о которых вам нужны данные в нужном вам формате и стиле данных. Наша команда аналитиков также может предоставить вам данные в сырых файлах Excel, сводных таблицах (книга фактов) или помочь вам в создании презентаций из наборов данных, доступных в отчете.

Часто задаваемые вопросы

Рынок сегментирован на основе Segmentation, By Dermatological Diseases (Acne, Dermatitis, Psoriasis, Skin Cancer, Others), Prescription mode  (Prescription Based Drugs, Over Counter Drugs), Drug Classification (Corticosteroids, Astringents, Anti-Inflammatory & Antipruritic Drugs, Anti-Infective/Antibacterial Drugs, Antifungal Drugs), Route Of Administration (Topical, Oral, Parenteral Administration), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), End User (Hospitals, Speciality Clinics, Cosmetic Centres) – Industry Trends and Forecast to 2031. .
Размер Global Dermatology Drugs Market в 2021 году оценивался в 20.79 USD Billion долларов США.
Ожидается, что Global Dermatology Drugs Market будет расти со среднегодовым темпом роста (CAGR) 10.25% в течение прогнозируемого периода 2022–2031.
Основные участники рынка включают LUPIN, Novartis AG, F. Hoffmann-La Roche Ltd, Pfizer , Sanofi, Amgen , Lilly, AstraZeneca, AbbVie , Johnson & Johnson Private Limited, LEO Pharma A/S, Merck & Co. , Bausch Health Companies , Bristol-Myers Squibb Company .
Отчет по рынку охватывает данные из U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..
Testimonial